Earnings get stamina from pension stake disposal

Similar documents
Equity Research

Equity Research

Lafarge Africa Plc. (WAPCO.NL)

Nigerian Inflation: Base effect to bow out as food pressures dictate CPI tone

EQUITY STRATEGY DIARY. Oyekunle Omotayo-Benson; Usman Olubajo

Nigeria Equities Financial Services August 23,

Zenith Bank Plc. Earnings Below Expectation: Lower Provision for Loan Loss Saves the Day. Nigeria Equities Financial Services August 15, 2018

2018 BUDGET. Budget of Consolidation

Key Developments in Domestic Economic and Policy Environment

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

The Company for Cooperative Insurance Insurance TAWUNIYA AB 8010.SE

Latest FY 16 result shows a percent YoY growth in Gross

ARM Research. Economic Update July Economic Report Monthly Update. 9 August FMDQ ignites further FX liquidity flame.

Institutional Equities

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Unilever Nigeria Plc. Cost control remains a challenge. Nigeria Equities Consumer Goods July 24, 2015

ARM Research. Economic Update -- October Economic Report Monthly update. Economic Research

MEDIA PRIMA (HOLD, EPS )

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Reduce. Punjab National Bank Banking RETAIL EQUITY RESEARCH. Not out of the woods. GEOJIT BNP PARIBAS Research. 10 th August 2016 Q1FY17 RESULT UPDATE

Unilever Nigeria Plc. Capital Bancorp Plc (Member of the Nigerian Stock Exchange) Passionately Eager to weather the storm. Investment Summary

SEVEN-UP BOTTLING COMPANY PLC

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Larsen & Toubro Ltd.

Technical Analysis: Market Insight

Company Overview. Financial Performance

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Sterling Bank PLC H Investor/Creditor Presentation. July 2011

HDFC Bank ACCUMULATE. Performance Highlights. CMP `2,348 Target Price `2,671. 4QFY2011 Result Update Banking. Key financials

Dangote Cement Plc. Higher Volume, Improved Pricing and Exchange Rate Benefit Impact Earnings. Nigeria Equities Industrial Goods May 18, 2018

OANDO PLC. Oando PLC: to be or not to be? Investment Summary & Highlight. MorganCapital Research. July 3, 2013

Financial Year End Results Presentation to Investors and Analysts

Fee income offsets margin pressure

Company Overview. Financial Performance

Financial Data Report SBM HOLDINGS LIMITED (THE GROUP) for the period ending 31.Dec.2016

Guotai Junan International [1788.HK]

Goodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Buy. Morning Call. Bank Al-Falah Limited (BAFL) IFC Capital Injection; EPS Accretive; Revised Earnings, BUY. November 10, 2014

Guaranty Trust Bank Plc

Profitability remained weak

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Jamna Auto Industries

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

PTC India Financial Services

Dangote Cement Plc. Improved Product Pricing Boosts Earnings. Nigeria Equities Industrial Goods April 3, 2018

ACCESS BANK RIGHTS ISSUE

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Chow Tai Fook (1929 HK)

Company Overview. Industry Overview. Financial Performance

Adani Ports & SEZ Rating: Target price: EPS:

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Earnings sustainability and asset quality remain under pressure

Nestlé India Outlook Hazy; Valuations Prohibitive

HDFC Bank. BUY CMP (Rs.) 1,807 Target (Rs.) 2,000 Potential Upside 11%

YG Entertainment (122870)

Buy Rating as per Mid Cap 12months investment period

Total Nigeria Plc. (Total: NL)

HOLD Rating as per Large Cap 12 month investment period

Company Overview. Industry Overview. Financial Performance

Results Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013

BUY CMP (Rs.) 297 Target (Rs.) 385 Potential Upside 30%

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

Market Access. Company Update. M&A Securities. Public Bank Berhad. Wednesday, April 27, BUY (Target Price: RM21.38) Proves to be Bellwether

Fineotex Chemical Ltd

Bupa Arabia for Cooperative Insurance Co. Insurance BUPA ARABIA 8210.SE

Colgate-Palmolive (India)

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

BUY. ICICI Bank RETAIL EQUITY RESEARCH. Banking. ddd******* GEOJIT Research. Strong traction in retail segment continues

Financial Data Report CIEL LTD (THE GROUP) for the period ending 31.Dec.2017

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

3,746 2,551 3, NIM

MTA Educational Web Series

Gillette India. Institutional Equities. 1QFY18 Result Update

Okomu Oil Palm Plc. Lower revenues, higher costs weaker profits. Equity Research PZ Cussons Nigeria. Nigeria Equities Consumer Goods December

MERISTEM EQUITY RESEARCH REPORT

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

All the more bullish, TP upgraded

Financial Data Report LOTTOTECH LIMITED. for the period ending 30.Jun.2017

BUY. Weak P&L performance, good b/s show POWER FINANCE CORP. Target Price: Rs 135. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

Financial Data Report LOTTOTECH LIMITED. for the period ending 31.Dec.2017

Financial Data Report LOTTOTECH LIMITED. for the period ending 30.Jun.2018

Korea Zinc (010130) Company Note. 1Q12 preview: Not over until it s over. BUY (Maintain)

Weekly Stock Recommendations 13 Nov 2017

Company Overview. Financial Performance

LG International (001120) Poor 3Q expected to be just a blip WHAT S THE STORY? SUMMARY OF 3Q RESULTS

Financial summary. Year

Samba Financial Group (SAMBA)

FORTE OIL PLC. FORTE OIL PLC: emergence of a new energy giant? Recommendation: HOLD FORTE OIL PLC FULL YEAR 2014:

Company Overview. Financial Performance

Fila Korea (081660) Widespread growth potential

Supermax. Rubber Gloves. Company Update. Bouncing back in BUY (maintain) Price Target: RM2.60 ( ) 26 January 2012

Financial Data Report SUN LIMITED (THE GROUP) for the period ending 31.Mar.2017

Financial Data Report MCB GROUP LIMITED (THE GROUP) for the period ending 31.Dec.2015

Market Access. M&A Securities. Results Review 1Q15. Malayan Banking Bhd BUY (TP: RM10.70) Stabilizing Period. Results Review

FLOUR MILLS OF NIGERIA PLC

Dalmia Bharat Enterprises

ICICI BANK Ltd. BUY CMP (Rs.) 334 Target (Rs.) 382 Potential Upside 15% Tide set to turn favourably... For private circulation only

Transcription:

Equity Research research@armsecurities.com.ng +234 1 270 1652 13 February 2017 Access Bank Plc. Stock Update Earnings get stamina from pension stake disposal Access disposes its stake in SIPML Late on Friday, Access filed a notice on the NSE that it had obtained regulatory approval for the disposal of its 17.6% stake in Stanbic IBTC Pensions Managers Limited (SIPML) - the pension subsidiary of Stanbic IBTC Holdings Plc. The disposal is in line with CBN s regulatory requirements in 2010 which mandated that banks without holding company s authorization divest equity holdings in non-core banking entities. SIPML is the largest pension fund administrator in Nigeria with 1.4million RSA contributors and AUM of N1.6 trillion using its most recent audited accounts (2015). Transaction raises prospect for sizable gain Access acquired the SIPML stake in 2007 for N75 million and as at 9M 2016 using a P/B multiple, the bank fair valued its stake at N957 million. Though the notice did not include information regarding the deal size, we look at data on precedent transactions in the sector over the last three years. (OVERWEIGHT: N7.96) Income Statement Data 2016 9M'm 2015 9M'm %chg Gross Earnings 274,468 257,590 7% PBT 72,004 60,372 19% Tax (14,909) (12,279) 21% PAT 57,095 48,093 19% Balance Sheet Data 2016-Sep 'm 2015 -Dec'm %chg Cash 603,595 478,409 26% Loans 1,800,939 1,365,831 32% Deposits 2,098,561 1,683,244 25% Fixed Asset 83,104 73,330 13% Net Assets 442,836 367,801 20% Stock Data Price N6.94 52-week range N3.60 N7.18 Market Cap. (N'm) 200,760 1-month Avg. Vol 25,038,143 Curr. PE 2.6x Bloomberg Ticker ACCESS:NL Access Bank Plc- Share Price Trend 8 7 6 5 4 3 Jan-16 Feb-16 Mar-16 Analyst(s) Apr-16 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Wale Okunrinboye adewale.okunrinboye@arm.com.ng

Table 1: Data on recent M&A in Nigerian PFA space Date Investor PFA Deal size ($'m) Stake Net Assets (N m) Transaction size to book value (x) 2014 Helios ARM Pensions 50.0 Minority* 3,792 n/a 2015 Actis Sigma Pensions 62.0 Majority* 3,444 n/a 2015 Axa Mansard Penman Pensions 9.5 60% 1,268 2.48 Source: Wall Street Journal, Actis, Axa Mansard Plc 2015 Annual report, ARM Research * no disclosure on size of stake In its most recent audited report, SIPML net assets stood at N17.8 billion implying Access share on book value basis of N3.1 billion. Using multiples from AXA Mansard s 60% acquisition of Penman Pensions at 2.5x net assets, we estimate that Access should have sold its take deal size of at least N7 billion which should generate a profit on its income statement. That said, Penman Pensions was a relatively small pension fund with AUM of circa 1% of SIPML. A naïve scaling for AUM size suggests potential valuation north of N12 billion. Overall, we see higher prospects for Access to report significant gains on this transaction in its income statement. In keeping with trends in the Nigerian environment where announcement of special dividends accompany disposals of investments, there exists higher prospects for a special dividend announcement. Nevertheless, given the current soft macro environment, one could argue that Access could retain some of the profits from the transaction to bolster capital buffers. We remain positive on Access ahead of FY 16E release We have been bullish on Access over the last one year as the bank positioned itself to be a beneficiary from naira weakness in 2016 via several cross-currency swaps ($900million outstanding as 9M 16). Furthermore, its low exposure to upstream O&G (5% of loan book) and no exposure to troubled power sector loans implied limited exposure to sectors facing macro headwinds. We think the announcement implies fresh upside to our earnings estimates (2016E: +21% YoY) and prospects for the announcement of a special dividend could spur share price rally. The stock closed 5% higher on Friday following the announcement.

Last weekend, the Access-Lagos Marathon took place with Kenyan runner Abraham Kiptum winning the 42km dash round the streets of Lagos for the second year running, shaving one minute of his 2016 time to finish the race in 2hours 15 minutes. As with the Kenyan, chances appear bright that Access looks set for the best FY 16 results announcement with a fresh burst of pace from the sale of the SIPML investment. We have positive view on Access with an OVERWEIGHT rating (FVE: N7.96). Figure 1: PBT/PAT growth and DPS PBT (N'billion) PAT (N'billion) DPS - RHS 100.00 90.00 80.00 70.00 60.00 50.00 40.00 30.00 20.00 10.00 0.00 75.23 65.87 42.86 43.06 37.50 16.71 2011 2012 2013 2014 2015 2016E 0.90 0.80 0.70 0.60 0.50 0.40 0.30 0.20 0.10 0.00 Source: Company financials, ARM Research On a related note, in the typical merger arbitrage move, Stanbic could succumb to negative sentiment as investors fret over the likely source of funding for the purchase of Access minority stake in SIPML. Given its failed attempt at raising capital, worry of potential cut in dividend payout ratios or fresh gearing to fund the purchase could spur bearish sentiments against the stock.

Summary of Results and Forecasts - Naira (N) QUARTERLY Income Statement (N 000)* Q1 2016A Q2 2016A Q3 2016A Q4 2016E Gross earnings 80,272 93,838 92,396 103,681 Interest Income 55,437 56,855 61,960 70,467 Interest Expense (20,814) (23,027) (24,681) (28,698) Net interest income 34,623 33,828 37,278 41,768 Non-Interest Revenue 24,737 36,982 30,437 33,271 OPEX (34,378) (35,556) (35,811) (41,661) Provisions (2,398) (7,814) (3,302) (17,078) PBT 22,583 27,440 28,602 16,301 Tax (3,164) (7,372) (4,290) 588 PAT 19,419 20,068 24,312 16,888 ANNUAL Income Statement (N 000) * FY 2014A FY 2015A FY 2016E FY 2017F FY 2018F Gross earnings 245,218 337,404 377,081 379,175 402,025 Interest Income 176,918 207,803 251,653 269,432 288,990 Interest Expense (76,901) (102,421) (107,901) (117,732) (140,481) Net interest income 100,017 105,382 143,752 151,700 148,509 Non-Interest Revenue 68,263 129,450 125,427 109,743 113,035 OPEX (104,605) (145,569) (150,603) (158,436) (167,687) Provisions (11,652) (14,225) (27,941) (24,814) (22,188) PBT 52,022 75,038 90,635 78,192 71,670 Tax (8,959) (9,169) (15,408) (15,638) (14,334) PAT 43,063 65,869 75,227 62,554 57,336 Balance Sheet (N 000) * Assets Net Loans 1,110,464 1,365,831 1,862,732 1,908,775 2,017,128 Fixed Assets 69,660 73,330 75,530 77,796 80,130 LT investment 357,284 389,939 497,905 522,800 548,940 Other Assets 104,616 161,099 402,596 431,481 449,626 Total Assets 2,104,361 2,591,330 3,494,355 3,587,471 3,737,058 Liabilities Deposits 1,454,419 1,683,244 2,188,218 2,231,982 2,298,941 Borrowings 221,567 386,889 560,988 594,648 630,327 Total liabilities 1,826,950 2,223,529 3,028,736 3,076,994 3,185,466 Shareholders' fund 277,411 367,801 465,619 510,477 551,592 Key Ratios FY 2014A FY 2015A FY 2016E FY 2017F FY 2018F EPS 1.88 2.59 2.60 2.16 1.98 DPS 0.60 0.57 0.78 0.65 0.59 BVPS 12.12 14.48 16.10 17.65 19.07 ROE 16.5% 18.3% 18.1% 12.8% 10.8% ROA 2.2% 2.6% 2.5% 1.8% 1.6% Financial Leverage 7.59 7.05 7.50 7.03 6.78 Asset yields 12.9% 11.5% 11.8% 11.1% 11.4% WACF 4.6% 4.8% 4.3% 4.0% 4.7% Net interest margins 7.3% 5.9% 6.7% 6.2% 5.9% Cost to income 62% 62% 56% 61% 64% Cost of risk 1.0% 1.0% 1.5% 1.3% 1.1% NPL ratio 2.2% 1.8% 2.5% 3.0% 2.5% Loan to Deposit 76% 81% 85% 86% 88% Liquidity ratio 28% 33% 38% 38% 38% Source: ARM Research *unless otherwise stated

ARM ratings and recommendations ARM now employs a two-tier rating system which is based on systemic importance of the security under review and the deviation of our target price for the stock from current market price. We characterize systemic importance as a function of a stock s ranking among the group of top 20 stocks by NSE market capitalization over a trailing 6 month period (minimum) to the review date. We adopt a 5 point rating system for this category of stocks and a 3 point rating system for stocks outside this group. The choice of top 20 stocks arises from the consideration that this group of stocks constitutes >75% of overall market capitalization and stocks outside this group are generally less liquid and individually account for <<1% of market capitalization. For stocks in both categories, the basis for ratings subject to target price deviation is outlined below: TOP 20 NON-TOP 20 Rating Deviation Rating Deviation STRONG BUY >20% BUY >20% OVERWEIGHT 10% 20 % NEUTRAL 5% 20 % NEUTRAL 0% 10 % SELL <5% UNDERWEIGHT -5% 0% SELL <-5% RECOMMENDATION KEY Rating BUY OVERWEIGHT NEUTRAL UNDERWEIGHT SELL Recommendation Accumulate security to a substantial extent constrained only by portfolio diversification considerations Accumulate security to an extent moderated by cognizance of its benchmark weight Maintain status quo for security with respect to current holding i.e. keep if already holding and don t buy otherwise subject to reasonab portfolio constraints Minimise exposure to security taking cognizance of its index weighting Sell-off security completely from portfolio

Copyright 2017 ARM Securities Limited ( ARMS ). All rights reserved. Unauthorised use, reproduction, distribution, or disclosure of this document is strictly prohibited. This material has been issued by ARM Securities Limited, a member of the Asset and Resource Management ( ARM ) Group, and a Company regulated by the Nigerian Securities & Exchange Commission. The analyst(s) primarily responsible for preparing this research report, in whole or in part, certifies that with respect to each security or issuer covered; all of the views expressed accurately reflect his/her personal views about the subject securities and issuers and no part of his/her compensation was, is, or will be, directly or indirectly, related to the inclusion of specific recommendations or views in the report. This research report is based on information from sources that ARMS and its analysts believe to be reliable. Neither ARMS nor any of its research analysts, nor any member of the ARM Group, gives any representation or warranty, express or implied, or undertaking of any kind or assumes responsibility or liability of any kind with respect to the accuracy or completeness of the information set out in this report or any third party s use (or the results of such use) of such information. This report is provided solely for informational purposes and is not to be construed as providing advice, recommendations, or endorsements of any kind whatsoever. The investments and strategies discussed here may not be suitable for all investors; counsel of investment advisor should be obtained with regard to such investments and or strategies. This research report is not a replacement for advice from an accountant, lawyer, personal finance advisor or other category of investment advisor. The investments discussed in this report may oscillate in price or value. Opinions and information provided are made as of the date of the report issue and are subject to change without notice. This research report is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Reference herein to any specific security or financial instrument does not necessarily constitute or imply its endorsement or recommendation by ARMS, its directors, officers, employees or designated agents. Members of ARM may act as broker, advisor or lender, or make a market in any investments or issuers referenced in this report. Further information on any of the securities discussed herein may be obtained upon request to ARMS. By accepting this document, you agree to be bound by the foregoing limitations.